Abcam PLC Fundamentals Datasheet and Stock Analysis


Abcam PLC Company Logo
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company's purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support.

  • Current Price:
  • Industry:
     Health Care
  • Sector:
     Health Care
  • ISIN:
  • Market Sector:
  • Main Indices:
  • Country of register:
     Great Britain
  • Currency:
  • Shares in Issue:
  • Market Cap:
  • Date Listed:
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)


Activity Data Not Available

Company Information

CEO: Alan Thomas Hirzel  CFO: Michael Baldock  Non-Executive Director: Giles Kerr, Mara G Aspinall, Bessie Lee Mark Capone  Non-Executive Chairman: Peter Allen  Senior Independent Director: Louise Patten  

  • Registrars:
  • Address:
     Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom
  • Phone:
     +44 (0)1223 696 000
  • Website:
Composite Ranking: 41
Historic EPS Ranking: 17
Forecast EPS Ranking: 
Price Relative Strength: 10
Industry Strength: C
SMR Ranking: B
ROCE Ranking: E
Accumulation/Dist: D
Mkt Accumulation/Dist: C
Unbroken Annual EPS: D
Unbroken Interim EPS: D
PEG Current Ranking: A
PEG Forecast Ranking: H
PE Current Ranking: H
PE Forecast Ranking: H
Margin Current Ranking: C
Margin Forecast Ranking: B
Add Indicator


Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Operating Profit/(loss)£m42.8543.3145.7346.3255.1468.8056.1010.50£m0.00
Profit Before Tax£m42.8943.5546.1045.4151.8769.1056.408.40£m48.09
Profit After Tax£m32.6634.0437.3837.4342.3662.2045.0012.50£m0.00
Profit After Tax (from discontinued operations)£m0.£m0.00
Overall Profit for the Period£m32.6634.0437.3837.4342.3662.2045.0012.50£m0.00
EPS Growth%
Earnings Per Sharep16.3417.0218.5718.5320.7430.2021.806.00p17.85
Op. Cash Flow P/Sp19.7320.6519.9823.4232.5230.7633.9630.06£0.00
Cash Flow P/S Grth%534.414.66(3.24)17.2238.86(5.41)10.40(11.48)%0.00
Net Cash Flow P/Sp0.£0.00
Capital Exp P/S££0.00
Tax Rate%
P/E Ratiox27.5022.0027.2039.5046.9043.7067.00230.20x85.00
P/E Growth££12.40
Turnover Per Share££0.00
Pre-Tax Profit / Share££0.00
Operating Margin%35.0633.8531.7526.9825.4029.5021.594.04%0.00
Mkt Cap£m930.12776.141,100.421,666.432,223.043,024.513,341.923,131.07£m0.00
Dividend Per Sharep7.047.758.218.9110.1812.0012.133.55p0.82
DPS Growth%
Dividend Yield%1.602.101.601.201.000.900.800.30%0.10
Dividend Coverx2.522.342.422.522.522.732.714.70x0.00
Shareholder Funds£m170.28180.90214.10261.19307.12351.70384.80502.60£m0.00
Net Borrowings£m(35.39)(55.28)(57.06)(68.92)(84.75)(90.20)(87.10)(187.30)£m0.00
Net Assets£m170.28180.90214.10261.19307.12351.70384.80502.60£m0.00
Net Assets P/S££0.00
Latest Forecast
Div Yield0.3%0.1%
Div Cover4.7%10.8%
Op Margin4.0%15.3%
Director Deals
Traded Action Notifier Price Amount Value
09-Mar-21BuyAlan Thomas Hirzel1,485.69p2,500,337,142.31
09-Mar-21BuyMichael Baldock20.66$5,000$85,181.83
03-Nov-20SellAlan Thomas Hirzel1,499.48p19,432£,291,378.76
17-Sep-20BuyPeter Allen1,253.00p3,602,345,133.06
17-Sep-20BuyMara G Aspinall1,253.00p1,623,320,336.19
17-Sep-20BuyLouise Patten1,253.00p1,126,314,108.78
17-Sep-20BuyGiles Kerr1,253.00p1,025,312,843.25
17-Sep-20BuyJonathan Simon Milner1,253.00p953,311,941.09
17-Apr-20Buy DividendsAlan Thomas Hirzel1,124.00p19£,213.56
29-Nov-19Buy DividendsAlan Thomas Hirzel1,326.00p39£,517.14
First PagePrev PageNext Page  Rows per page
227m    Major: 32%    Director: 0%
Notifier Holding Value
Alan Thomas Hirzel203,911,887,379.76
Louise Patten54,842̈,562.72
Peter Allen18,563Ć,852.08
Mara G Aspinall14,545Í,957.20
Michael Baldock5,000F,800
  Rows per page
Gearing & Cover
News Title Date Time Source
Statement re Update on 2019 AGM Resolution Vote11-May-2011:00RNS
Total Voting Rights01-May-2012:24RNS
Holding(s) in Company22-Apr-2010:11RNS
Director/PDMR Shareholding21-Apr-2007:26RNS
Holding(s) in Company20-Apr-2010:19RNS
COVID-19 Update20-Apr-2007:00RNS
Holding(s) in Company14-Apr-2010:07RNS
Issue of Shares09-Apr-2017:33RNS
Total Voting Rights02-Apr-2009:50RNS
Holding(s) in Company27-Mar-2015:37RNS
First PagePrev PageNext Page  Rows per page
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change
10-Mar-21Berenberg BankHold1533.00p1180.00p1300.00pReiteration
09-Mar-21JP Morgan CazenoveNeutral1494.00p1400.00p1300.00pReiteration
17-Dec-20Peel Hunt LimitedHold1444.00p0.00p1530.00pReiteration
12-Nov-19RBC Capital MarketsSector perform1260.00p0.00p1300.00pReiteration
11-Nov-19Liberum CapitalHold1249.00p0.00p1230.00pReiteration
18-Mar-15Investec SecuritiesHold486.00p0.00p0.00pDownGrade
09-Mar-15N 1 SingerSell471.75p0.00p0.00pReiteration
09-Mar-15Canaccord GenuityHold471.75p0.00p432.00pReiteration
09-Mar-15Numis SecuritiesBuy472.75p580.00p580.00pReiteration
First PagePrev PageNext Page  Rows per page

This functionality requires you to login

Click here to login
Or register for a new account